RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Pretax margin (%)

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 202428.5+6.94%
Dec 31, 202326.6-18.95%
Dec 31, 202232.8+0.95%
Dec 31, 202132.5+55.64%
Dec 31, 202020.9-22.10%
Dec 31, 201926.8+31.18%
Dec 31, 201820.5-32.11%
Dec 31, 201730.1+21.00%
Dec 31, 201624.9-0.24%
Dec 31, 201525-49.32%
Dec 31, 201449.2+95.49%
Dec 31, 201325.2+22.36%
Dec 31, 201220.6+21.86%
Dec 31, 201116.9-8.85%
Dec 31, 201018.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)